Skip to main content

Table 3 Sensitivity of FACT-Ga scores and EQ-5D utility to clinical severity

From: Validation of the functional assessment of cancer therapy-gastric module for the Chinese population

  Treatment intent Clinical stage*
  Curative (n = 48) Palliative (n = 19) Effect size P Early stage (n = 49) Late stage (n = 18) Effect size P
  Mean ± SD Mean ± SD    Mean ± SD Mean ± SD   
PWB 24.8 (3.90) 23.1 (4.36) 0.45 0.112 24.7 (4.01) 23.4 (4.24) 0.32 0.264
SWB 21.3 (5.86) 21.9 (4.34) −0.10 0.686 20.9 (5.94) 23.1 (3.48) −0.36 0.079
EWB 20.6 (2.95) 18.7 (4.11) 0.65 0.036 20.4 (2.97) 19.3 (4.38) 0.36 0.256
FWB 20.6 (6.26) 16.0 (6.31) 0.74 0.008 19.9 (6.52) 17.5 (6.60) 0.37 0.180
GCS 61.4 (11.59) 56.1 (13.1) 0.46 0.106 61.8 (10.95) 54.8 (14.10) 0.64 0.035
FACT-G 87.4 (13.77) 79.6 (15.30) 0.56 0.049 85.9 (14.57) 83.2 (14.70) 0.18 0.511
FACT-Ga 148.5 (22.76) 135.2 (6.77) 0.59 0.044 147.4 (22.99) 137.5 (27.70) 0.43 0.146
EQ-5D 0.86 (0.24) 0.65 (0.33) 0.89 0.016 0.84 (0.25) 0.68 (0.33) 0.66 0.031
  1. *Early stage: AJCC stages 0–3; Late stage: AJCC stage 4.